Tammy Lewis

Chief Marketing Officer, CVS Caremark and CVS Specialty
Tammy Lewis

Lewis is the Chief Marketing Officer, CVS Caremark and CVS Specialty. She joined CVS Health in 2014 and is responsible for payor and provider marketing, member engagement and customer experience.

Lewis has spent over 25 years in healthcare with a heavy focus in B2B and B2B2C marketing. She is passionate about the role of technology to improve the overall healthcare system and the important role that member experience has on improving health outcomes. Lewis was the founding Chief Marketing Officer at Surescripts, where she was responsible for the development of the company’s e-prescribing go-to-market and growth strategies. Prior to Surescripts, she was the senior vice president of marketing at Medscape, the leading online destination for physicians and healthcare professionals, and head of the HIV franchise at Hoffmann La Roche. Immediately prior to joining CVS Health, Lewis headed a marketing consultancy with a focus on healthcare and technology start-ups.

Lewis holds a Bachelor’s Degree in marketing from the University of Maryland and an MBA from the Stern School of Business at New York University.

Innovation
How CVS Health is Driving Better Care and Cost Savings for Plan Sponsors, Members with Continuous Improvement and Innovation More
Commentary
Father checking his Rx delivery options on phone at breakfast table
Innovation
Innovative prescription delivery options -- same-day, on demand, and one- to two-day delivery -- offer members greater convenience. More
Briefing
Man using a tablet device in his kitchen
Government Programs and Services
Extensive consumer research informs our toolkit, which can help payors educate and encourage members to try mail service pharmacy, and may help control plan costs and improve... More
Briefing
Lady in living room, reviewing her mail
Innovation
Consumer research helps to ensure that communications resonate with PBM members, facilitating their transition to a new benefit plan, formulary or network. More
Briefing